January 23, 2023
Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.
August 2, 2021
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
July 24, 2012
Dr. Davey Smith, associate professor of medicine at the UC San Diego School of Medicine and the VA San Diego Health System is one of three recipients of the 2012 Avant-Garde Award for HIV/AIDS research.
March 19, 2018
Each year people all over the world die from the flu. To protect against influenza epidemics and their potentially mortal results, medical professionals encourage vaccination. While generally effective for healthy individuals, vaccinations are less effective for the elderly, the immunocompromised and other high-risk groups. For the healthy, getting a shot…
November 30, 2020
University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.
February 25, 2020
A team of researchers from the University of California San Diego and the University of Pittsburgh offers a new approach for developing treatments for pandemic Influenza A (pH1N1).
October 3, 2013
…effective way of developing drugs to treat the flu virus. Now, his name and his study have gone viral. Chen, a senior at Canyon Crest Academy, has been awarded the grand prize in the Google Science Fair. His project, “The Taming of the Flu,” was chosen in the competition open…
April 24, 2012
…the advent of antiretroviral drugs (prescribed in the early stages of infection) can often render HIV/AIDS a chronic but livable condition. Patients can live relatively normal, full lives for decades after diagnosis. Perhaps the greater challenge now is preventing HIV infection in the first place, particularly among persons at high…
March 22, 2023
UC San Diego researchers describe why SARS-CoV-2 subvariants spread more rapidly than the original virus strain, and how an early treatment might have made people more susceptible to future infections.
August 15, 2017
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a desert plant common to the Southwestern United States, exhibit potent anti-parasitic activity against the protozoa responsible for…
